Key Takeaways
- • Private equity investment in U.S. healthcare has surged from $41.5 billion in 2010 to $119.9 billion in 2019, with growth expected to continue, according to the American College of Physicians' new position paper published in Annals of Internal Medicine on May 25, 2026.
- • The American College of Physicians calls for increased regulatory oversight and policy protections to safeguard patients and physicians from adverse impacts of private equity consolidation in healthcare, citing evidence linking PE investment to higher costs and, in certain settings, deteriorated care delivery and patient outcomes.
- • Private equity firms' emphasis on short-term profit maximization poses systemic risks to healthcare delivery, including practice closures, physician workforce instability, reduced clinical autonomy, and potential patient safety complications, according to multiple healthcare policy analyses.
- • PE investment patterns have increasingly targeted primary care and multispecialty practices as physicians have abandoned private practice due to financial pressures, inadequate reimbursement, and burnout, creating conditions favorable for institutional capital acquisition by firms lacking healthcare expertise.
- • Regulatory solutions recommended include enhanced oversight mechanisms and policy frameworks designed to align private equity incentives with patient-centered care rather than short-term financial extraction strategies.
Summary
The American College of Physicians issued a formal position paper on May 25, 2026, warning that private equity's expanding role in healthcare requires substantial regulatory intervention to protect patient safety and physician autonomy. Published in *Annals of Internal Medicine*, the paper examines PE's systemic impact across clinical autonomy, healthcare costs, quality, access, equity, and innovation—areas where evidence increasingly suggests misalignment between PE profit objectives and healthcare delivery outcomes.
Private equity capital flowing into U.S. healthcare has accelerated dramatically. Investment grew from $41.5 billion in 2010 to $119.9 billion by 2019, with projections indicating continued expansion. This capital influx has fundamentally altered the practice acquisition landscape, particularly in primary care and multispecialty settings. Traditionally, physicians financed and controlled their own practices; today, financial pressures—including high operational costs, inadequate reimbursement rates, and physician burnout—have driven practitioners toward institutional investors. Institutional PE firms, which may lack healthcare delivery expertise, have filled this financing void, shifting control of medical practices away from physician ownership.
The ACP's concern centers on PE's structural incentive misalignment. Private equity models prioritize short-term profitability and asset extraction over sustained care quality. According to the ACP and supporting research, this approach correlates with higher patient costs, reduced care quality in certain settings, and adverse patient outcomes. In some cases, PE-owned practices have experienced closure or bankruptcy, disrupting patient access and destabilizing physician employment. Additionally, PE ownership has been associated with reduced clinical autonomy for physicians and workforce instability.
Jan K. Carney, MD, MPH, MACP, president of the ACP, stated that given PE's increasing systemic role, comprehensive understanding of its impact is essential. The organization advocates for regulatory frameworks and policies that ensure patient-centered care remains the priority, addressing what it views as inadequate current oversight of PE acquisition strategies and operational practices in healthcare delivery.
Private equity capital flowing into U.S. healthcare has accelerated dramatically. Investment grew from $41.5 billion in 2010 to $119.9 billion by 2019, with projections indicating continued expansion. This capital influx has fundamentally altered the practice acquisition landscape, particularly in primary care and multispecialty settings. Traditionally, physicians financed and controlled their own practices; today, financial pressures—including high operational costs, inadequate reimbursement rates, and physician burnout—have driven practitioners toward institutional investors. Institutional PE firms, which may lack healthcare delivery expertise, have filled this financing void, shifting control of medical practices away from physician ownership.
The ACP's concern centers on PE's structural incentive misalignment. Private equity models prioritize short-term profitability and asset extraction over sustained care quality. According to the ACP and supporting research, this approach correlates with higher patient costs, reduced care quality in certain settings, and adverse patient outcomes. In some cases, PE-owned practices have experienced closure or bankruptcy, disrupting patient access and destabilizing physician employment. Additionally, PE ownership has been associated with reduced clinical autonomy for physicians and workforce instability.
Jan K. Carney, MD, MPH, MACP, president of the ACP, stated that given PE's increasing systemic role, comprehensive understanding of its impact is essential. The organization advocates for regulatory frameworks and policies that ensure patient-centered care remains the priority, addressing what it views as inadequate current oversight of PE acquisition strategies and operational practices in healthcare delivery.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.